![]() ![]() Fluent In English is a must, second European language a plus.Experienced in start-up environment a plus.Excellent skills in data management and project management.Proven track record of achieving targets and goals - in a complex and dynamic company.experience in a global or regional role supporting Market Access and Tender Business successful experience from Tender business or Market Access positions within a pharmaceutical company Possibility to engage in other ad hoc sales operation and Market Access projects.Administratively responsible for a centralized tendering system and CRM Inclusion.Continuously keep the supply chain team updated on the tender situation and progress in Europe and follow up on product supply to fulfil local contracts.Act as the link between the Global & European Market Access Team, European Management Team and the local tender managers.Continuous follow up on Country Tender processes.Support preparations of Tender applications and follow up.In close collaboration with the local Tender Managers support and ensure that all needed data is available to progress with local lenders.Provide the local Tender Managers with guidance based on the Global and European strategy.Drive and develop the European Tender Strategy in close collaboration with the Global & European Market Access Team and the European Management Team.Collect, develop and own the overview and tracking of the tender situation in Europe. ![]() This position reports to the European Head of Customer Engagement and Market Access with a close collaboration with the Global and European Market Access Team. You will act as the link between the Global & European Market Access Team, the European Management Team and the local Tender Managers. This position will support the European region with coordination, guidance and oversight of the European Tender Management. We are seeking an Associate Director Tender Management Europe. Our vaccine technology combines the power and speed of genetic engineering with the immunogenicity enhancing properties of our Matrix-M™ adjuvant to efficiently produce highly immunogenic particles targeting some of the most pressing viral infectious diseases. ![]() Our scientists are committed to developing vaccine candidates for some of the world’s toughest viral threats by utilizing the power of our innovative recombinant nanoparticle vaccine platform. Hard-won lessons and significant advances illustrate that our proven technology has tremendous potential to make a substantial contribution to public health worldwide. We have more than a decade of experience contending with some of the world’s most devastating diseases, including COVID-19, seasonal influenza, RSV, Ebola, MERS, and SARS. Novavax, Inc (Nasdaq:NVAX) is a biotechnology company that creates transformational vaccines that address some of the world’s most pressing infectious diseases. If you find science, speed, and success exhilarating, you have come to the right place. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |